Healthcare -
Biotechnology - NASDAQ - US
$ 300.27
-2.2 %
$ 6.63 B
Market Cap
-13.47
P/E
MDGL - STOCK-BASED COMPENSATION
Stock-based Compensation MDGL - Madrigal Pharmaceuticals, Inc.
79.9 M
LAST VALUE
58.93%
2 YEAR CAGR
28.55%
5 YEAR CAGR
26.81%
10 YEAR CAGR